[ad_1]
In recent weeks, positive news emerged about vaccines developed against the corona virus, and today, US-based Moderna gave hope …
Modern, based in the United States, shared with the public the results of the third phase of the corona virus vaccine. In the statement made, it was indicated that there were no side effects in the third phase of the vaccine, and it was emphasized that the vaccine prevented the transmission of Covid-19 by 100 percent. As a result of investigating 196 Covid-19 cases, the vaccine was claimed to be 94.1 percent effective.
Moderna CEO Stephane Bancel said: “We hope that our vaccine will be a powerful new weapon that can change the course of the pandemic. We hope it reduces serious illness, hospitalization and mortality, ”he said. In the statement made, it was also noted that the vaccine had no serious side effects.
Dr. “We think we have a very effective vaccine,” Tal Zaks said in a statement. “We now have the data to prove this,” he said. Dr. “We hope to play an important role in eradicating this epidemic,” he said in a statement challenging the corona virus outbreak by Tal Zaks.
HOW WAS THE VACCINE TESTED?
In the third phase that Moderna made public, 30,000 people residing in the United States were included. 196 of these participants were infected with the corona virus, 185 of them received a placebo, and 11 of them received the vaccine. While 30 of the study participants became seriously ill, one person died, but these volunteers did not receive Moderna’s vaccine. Therefore, Moderna’s vaccine was determined to provide 100 percent protection.
7,000 people over the age of 65 were included in the study, while 5,000 young people with chronic diseases such as obesity, diabetes and heart disease were included. It was claimed that 11,000 people of ethnic origin were included in the study, and this number was also on the same scale as the US population.
Moderna announced that it has not yet made the entire investigation public. Moderna’s research will be shared after it is published in a peer-reviewed journal.
95 PERCENT EFFECTIVE
Following BioNTech, it was announced that the first vaccine data developed by the American biotechnology company Moderna against the new type of corona virus (Covid-19) revealed that the vaccine was 95.4 percent effective.
Moderna also emphasized that the vaccine will be requested for conditional approval from both the US National Food and Drug Administration (FDA) and the European Medicines Agency.
It may interest you
It may interest you
[ad_2]
